药大主站 | 设为首页 | 加入收藏 | 联系我们
 
您当前位置: 沈阳药科大学研究生教育网 >> 学科建设 >> 学术报告 >> 浏览文章

The role and function of pharmaceutical analysis in new drug development

作者:佚名 来源:本站原创 浏览: 发布时间:2014-06-06 09:23:54 【字体:

 

报告人:Yong GUO 教授

School of Pharmacy, Fairleigh Dickinson University, USA

报告题目:The role and function of pharmaceutical analysis in new drug development

(药物分析在新药研发中的地位作用和方法)

报告时间:2014613日(周五)14:00

报告地点:图书馆五楼第一学术报告厅

主办单位:研究生处(学科建设办公室)

药物分析学(药学信息学)学科

          

报告人简介:

Dr. Guo is currently Professor of Pharmaceutical Science at School of Pharmacy, Fairleigh Dickinson University, the largest private university in the state of New Jersey, US. Dr. Guo holds a Ph.D degree in chemistry from the State University of New York at Buffalo as well as a MBA degree in Pharmaceutical Management from Fairleigh Dickinson University. Dr. Guo is also a graduate of University of Science and Technology of China, majoring in chemistry and English. Dr. Guo joined the FDU School of Pharmacy in 2012 following a productive 15-year career in pharmaceutical industry. At FDU, Dr. Guo teaches professional Doctor of Pharmacy students in the area of pharmaceutical sciences, including Physical Pharmacy, Pharmaceutical Calculation, Pharmaceutical Biotechnology, and Pharmacokinetics. In addition, Dr. Guo also serves as Director for Research overseeing the research programs at the FDU School of Pharmacy.

Prior to his academic career, Dr. Guo was an Associate Director at Janssen Pharmaceutical Research and Development, a pharmaceutical company of Johnson & Johnson. At Johnson & Johnson, Dr. Guo was primarily responsible for managing project teams in support of new drug development and registration. Dr. Guo has led the analytical development teams working on numerous projects both at the early and late stages, including method development and validation, release testing, stability studies, technology transfer and regulatory filing. During his tenure at Johnson & Johnson, Dr. Guo was directly involved in supporting 4 New Drug Application (NDA) filings in US and one Market Approval Application (MAA) filing in Europe. For his outstanding contribution to the filing and approval of Edurant (Rilpivirine), Dr. Guo was awarded the Standard of Leadership award by Johnson & Johnson.


注册地址:辽宁省沈阳市沈河区文化路103号 邮编:110016
通信地址:辽宁省本溪高新技术产业开发区华佗大街26号 邮编:117004
     办公地点:南校区行政楼二楼